Welcome to our dedicated page for Tomi Environmental Solutions I news (Ticker: TOMZ), a resource for investors and traders seeking the latest updates and insights on Tomi Environmental Solutions I stock.
TOMI Environmental Solutions, Inc. reports developments tied to disinfection and decontamination products built around SteraMist iHP and Binary Ionization Technology. Company news commonly covers biocidal regulatory approvals, SteraMist applications in healthcare, life sciences, food safety, commercial facilities, transportation and remediation settings, and product categories such as BIT Solution consumables, integrated systems, mobile equipment and iHP Corporate Service offerings.
Updates also include operating and financial results, customer and service activity, training and application protocols, shareholder voting matters, governance topics, capital-structure disclosures and material agreements. TOMI's recurring business themes include the installed base for SteraMist delivery systems, consumable BIT Solution demand, engineered decontamination systems and professional decontamination services.
TOMI Environmental Solutions (NASDAQ:TOMZ) reported preliminary Q2 2026 revenue of approximately $2.3 million, a 124% year-over-year increase. With $6.2 million in open orders, preliminary six-month revenue plus open orders already exceed full-year 2025 revenue.
Key highlights include strong growth across mobile capital equipment, accessories, support services, applicators, and BIT Solution, with gross margin expanding to 70%. SteraMist received 2026 Disinfection and Decontamination Products Company of the Year honors, while TOMI added new distributors and secured notable automation and healthcare projects, including a customized NV+ deployment scheduled for Q3.
TOMI Environmental Solutions (NASDAQ:TOMZ), which plans to merge with Carbonium Core, highlighted an interview detailing Carbonium Core’s strategy to build what management believes could be America’s first commercial-scale domestic supply chain for nuclear-grade graphite.
Management outlined a phased roadmap from pilot production to a planned commercial facility targeting about 50,000 metric tons of nuclear-grade graphite annually, which it estimates could represent a long-term revenue opportunity approaching $1.5 billion, subject to successful execution, financing, demand, pricing and approvals.
Key milestones include qualifying materials with advanced reactor developers, signing letters of intent and long-term supply agreements, advancing the pilot facility, deploying proprietary Oak Ridge National Laboratory-licensed technology, and securing government financing and strategic partnerships. Management positions Carbonium Core at the convergence of AI-driven data center growth, advanced nuclear energy and domestic critical-mineral supply chains.
TOMI Environmental Solutions (NASDAQ:TOMZ) signed a definitive Merger Agreement with Carbonium Core, a U.S. developer of graphite and rare earth metals for advanced nuclear, defense, and critical infrastructure applications.
Subject to approvals and conditions, Carbonium shareholders are expected to own about 90% of the combined company. Closing is targeted for Q3 2026, contingent on at least $10 million in financing and NASDAQ listing approval. The combined business aims to be a pure-play on nuclear-grade graphite and critical materials, support advanced reactor supply chains, and help TOMI improve capital access, balance sheet strength, and NASDAQ compliance while exploring cross-platform technology integration.
TOMI Environmental Solutions (NASDAQ:TOMZ) reports accelerating customer adoption of its SteraMist decontamination platform as Ebola and other outbreaks increase global biosecurity spending. Healthcare systems, emergency response teams, transportation operators, and preparedness programs are broadening deployments in the U.S. and internationally to strengthen infection prevention and long-term operational readiness.
TOMI (NASDAQ:TOMZ) announced a key step toward NSF certification for its patented SteraMist ionized Hydrogen Peroxide (iHP) decontamination technology. TOMI and partner Total Clean Air are presenting to the NSF Joint Committee on Biosafety Cabinets to define validation studies across multiple biosafety cabinet types.
Management believes NSF certification could support wider SteraMist adoption in pharmaceutical manufacturing, biotechnology, cleanrooms, research labs, and other high-containment facilities, helping address multi‑billion‑dollar contamination‑control markets and potentially expanding TOMI’s addressable market and recurring revenue opportunities.
TOMI Environmental Solutions (NASDAQ:TOMZ) outlines growing biosecurity demand ahead of the 2026 FIFA World Cup, expected to attract about 6.5 million fans across North America.
The company highlights increased inbound interest and investments in its SteraMist iHP disinfection technology from healthcare and other critical sectors worldwide.
TOMI describes the World Cup as a catalyst for long-term biosecurity adoption across transportation, hospitality, food systems, public venues, and defense, suggesting a potential multi-billion-dollar market opportunity.
TOMI Environmental (NASDAQ:TOMZ) outlined plans to extend its SteraMist® disinfection platform into AI, robotics and drone-enabled deployment across sectors such as robo-taxis, agriculture, transportation, critical infrastructure and public health.
The company highlights potential long-term demand for automated biosecurity solutions as emerging pathogens raise global infection-control priorities.
TOMI Environmental Solutions (NASDAQ:TOMZ) highlighted rising demand for its SteraMist ionized Hydrogen Peroxide (iHP) disinfection technology amid global norovirus, Ebola and hantavirus alerts. NASA recently selected SteraMist for a Mars Sample Return biosecurity operation, while hospitals, cruise lines, schools and government facilities seek automated, scalable contamination-control solutions.
The technology is designed to rapidly disinfect large spaces, address norovirus’ environmental stability, and support high-consequence pathogen containment for specialized medical transport groups and Regional Emerging Special Pathogen Treatment Centers.
TOMI (NASDAQ:TOMZ) received new regulatory approvals in Austria and Italy for its Binary Ionization Technology (BIT), advancing its European expansion. BIT is now authorized in Austria, Italy, the Netherlands, Belgium, Denmark, Germany, Hungary, Great Britain, and Northern Ireland under the EU Biocidal Products Regulation (BPR).
Approved as a PT2 disinfectant in the Netherlands since March 2026, BIT can use BPR’s mutual recognition process to streamline authorization in additional EU states. Parallel mutual recognition is anticipated for France, Ireland, Poland, Portugal, Romania, and Spain, supporting faster regional rollout.
TOMI Environmental Solutions (NASDAQ:TOMZ) announced a signed purchase order for a custom SteraMist Hybrid system from a food producer, following multi-year use of its portable SteraPak technology.
The new installation will serve as permanent infrastructure in an expanded facility to support pathogen control, regulatory compliance, and reduced production downtime.